Andor Health Advances AI-Native Virtual Nursing With MUSC
Orlando, Florida, USA, August, 10, 2026 Independent research from the Medical University of South Carolina (MUSC) Telehealth Center of...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Orlando, Florida, USA, August, 10, 2026 Independent research from the Medical University of South Carolina (MUSC) Telehealth Center of...
DALLAS, July 22, 2026 Cosmetic Physician Partners (CPP) has announced a $35 million capital distribution to its practitioner-shareholders, marking...
AMSTERDAM, Netherlands, June 9, 2026 Artificial intelligence is already delivering measurable benefits across healthcare systems, saving clinicians the equivalent...
WINDHAM, New Hampshire | January 6, 2026 — Medicus Healthcare Solutions has released a comprehensive new report examining the...
